A Single-Center, Open-Label Pilot Study Comparing De Novo Letermovir versus Valganciclovir for Cytomegalovirus Prophylaxis in African American Kidney Transplant Recipients

Valcyte (valganciclovir) - Roche, Tanabe Pharma

Prevymis (letermovir) - Merck (MSD)

I. Yakubu; G. Abebe; D. Kumar; A. Brown; I. Moinuddin; M. Morales; S. Sterling; A. T. Iaria; B. Agegnehu; R. Marks; T. Sprague; M. Saeed; G. Gupta

Jun 17, 2026